Literature DB >> 2542204

Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection.

S Ishihara1, A Tawa, K Yumura-Yagi, M Murata, J Hara, H Yabuuchi, K Hirai, K Kawa-Ha.   

Abstract

A 10-year-old boy with chronic active Epstein-Barr virus (EBV) infection developed T-cell lymphoproliferation in the terminal stage of hepatic failure. The phenotypes of the proliferating lymphocytes were CD3+, CD4+ and HLA-DR+. The genomic DNAs from these cells demonstrated two rearranged T-cell receptor beta-chain genes and contained the EBV genome. These findings indicate that EBV can infect T lymphocytes and might cause clonal T-cell lymphoproliferation.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2542204      PMCID： PMC5917706          DOI： 10.1111/j.1349-7006.1989.tb02273.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


  15 in total

1.  Remarkable depression of CD4+2H4+ T cells in severe chronic active Epstein-Barr virus infection.

Authors:  E Franco; K Kawa-Ha; S Doi; K Yumura; M Murata; S Ishihara; A Tawa; H Yabuuchi
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Kappa-chain gene rearrangement in an apparent T-lineage lymphoma.

Authors:  K Ha-Kawa; J Hara; Y Keiko; A Muraguchi; N Kawamura; S Ishihara; S Doi; H Yabuuchi
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

4.  Association of Epstein-Barr virus with thymic carcinoma.

Authors:  S Leyvraz; W Henle; A P Chahinian; C Perlmann; G Klein; R E Gordon; M Rosenblum; J F Holland
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

5.  Epstein-Barr virus. Infection and tumour induction.

Authors:  M A Epstein
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

6.  Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.

Authors:  T Dambaugh; C Beisel; M Hummel; W King; S Fennewald; A Cheung; M Heller; N Raab-Traub; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.

Authors:  R I Fox; G Pearson; J H Vaughan
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

8.  Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.

Authors:  W T Shearer; J Ritz; M J Finegold; I C Guerra; H M Rosenblatt; D E Lewis; M S Pollack; L H Taber; C V Sumaya; F C Grumet
Journal:  N Engl J Med       Date:  1985-05-02       Impact factor: 91.245

9.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

10.  Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.

Authors:  W Andiman; L Gradoville; L Heston; R Neydorff; M E Savage; G Kitchingman; D Shedd; G Miller
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226
View more
  17 in total

Review 1.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

Review 2.  How we treat chronic active Epstein-Barr virus infection.

Authors:  Akihisa Sawada; Masami Inoue; Keisei Kawa
Journal:  Int J Hematol       Date:  2017-02-16       Impact factor: 2.490

3.  Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.

Authors:  Michiko K Oyoshi; Hiroshi Nagata; Nobuhiro Kimura; Yu Zhang; Ayako Demachi; Toshiro Hara; Hirokazu Kanegane; Yoshinobu Matsuo; Tomohiro Yamaguchi; Tomohiro Morio; Atsuyoshi Hirano; Norio Shimizu; Kohtaro Yamamoto
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 4.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

Authors:  I J Su; R L Chen; D T Lin; K S Lin; C C Chen
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

6.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

Review 8.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

9.  NK/T-cell lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus: an autopsy case.

Authors:  Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jin Soo Lee; Min Ja Kim; Woon Yong Jung; Han Kyeom Kim; Bum-Woo Yeom; In-Sun Kim; Jun Suk Kim
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

10.  Monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome.

Authors:  T Noma; K Kou; I Yoshizawa; Y Kawano; T Miyashita; S Mizutani; J Yata
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.